Fosun Pharma pharmaceutical manufacturing and R & D business continue to maintain steady growth, and the construction of professional management team is further strengthened. In 2015, the Group’s sales of major core products of cardiovascular system, metabolism and digestive system, anti infection and anti-tumor and other disease treatment fields maintain a relatively rapid growth.
In 2015, the sales of a total of 19 preparation single item or series exceeded 100 million yuan. In the global market, Fosun Pharmaceutical Group has also become leader of antimalarial drugs.
About other business of Fosun Pharma